CO5231134A1 - Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica con efecto antitumoral - Google Patents
Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica con efecto antitumoralInfo
- Publication number
- CO5231134A1 CO5231134A1 CO99068636A CO99068636A CO5231134A1 CO 5231134 A1 CO5231134 A1 CO 5231134A1 CO 99068636 A CO99068636 A CO 99068636A CO 99068636 A CO99068636 A CO 99068636A CO 5231134 A1 CO5231134 A1 CO 5231134A1
- Authority
- CO
- Colombia
- Prior art keywords
- composition according
- pharmaceutical composition
- dna molecules
- muc
- clause
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 230000000259 anti-tumor effect Effects 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 108020004414 DNA Proteins 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001136—Cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002330A IT1303683B1 (it) | 1998-10-30 | 1998-10-30 | Composizione farmaceutiche ad azione antitumorale contenente dnacodificante per frammenti di una proteina antigenica. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5231134A1 true CO5231134A1 (es) | 2002-12-27 |
Family
ID=11380969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO99068636A CO5231134A1 (es) | 1998-10-30 | 1999-10-29 | Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica con efecto antitumoral |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1124956A2 (ja) |
| JP (1) | JP2002528519A (ja) |
| CN (1) | CN1324406A (ja) |
| AR (1) | AR020927A1 (ja) |
| AU (1) | AU1152200A (ja) |
| BG (1) | BG105458A (ja) |
| BR (1) | BR9914892A (ja) |
| CA (1) | CA2348745A1 (ja) |
| CO (1) | CO5231134A1 (ja) |
| CZ (1) | CZ20011521A3 (ja) |
| EA (1) | EA200100395A1 (ja) |
| HU (1) | HUP0103784A2 (ja) |
| IT (1) | IT1303683B1 (ja) |
| MX (1) | MXPA01004186A (ja) |
| PE (1) | PE20001287A1 (ja) |
| PL (1) | PL348156A1 (ja) |
| SK (1) | SK5712001A3 (ja) |
| TR (1) | TR200101141T2 (ja) |
| WO (1) | WO2000025827A2 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548643B1 (en) | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
| WO2001057068A1 (en) * | 2000-02-01 | 2001-08-09 | The Austin Research Institute | Mucin-1 derived antigens and their use in immunotherapy |
| AU9263101A (en) * | 2000-09-11 | 2002-03-26 | Donald W Kufe | Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| JP4276432B2 (ja) | 2000-12-22 | 2009-06-10 | ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド | Ｍｕｃ１による細胞増殖調節方法 |
| JP4616827B2 (ja) * | 2003-03-24 | 2011-01-19 | ザ スクリプス リサーチ インスティチュート | 腫瘍成長に対するｄｎａワクチン及びその使用方法 |
| US7696306B2 (en) | 2003-07-11 | 2010-04-13 | Board of Agents of the University of Nebraska | Compositions and methods for preventing or treating cancer |
| US8129506B2 (en) | 2003-10-24 | 2012-03-06 | Genzyme Corporation | Modulation of the interaction of MUC1 with MUC1 ligands |
| US7871784B2 (en) | 2007-02-02 | 2011-01-18 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins |
| US7972870B2 (en) | 2007-02-02 | 2011-07-05 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3 |
| CN106279435B (zh) * | 2016-08-16 | 2019-06-07 | 新乡医学院 | 靶向VEGF与mucin1的抗肿瘤疫苗、编码基因、表达载体、表达工程菌及应用 |
| CN113321724B (zh) * | 2021-03-24 | 2022-02-01 | 深圳市新靶向生物科技有限公司 | 一种与食道癌驱动基因突变相关的抗原肽及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1262545B (it) * | 1993-10-25 | 1996-07-02 | Menarini Ricerche Sud S P A A | Sistema di espressione per linee cellulari eucariotiche |
| CA2282300C (en) * | 1997-02-24 | 2011-08-02 | Therion Biologics Corporation | Recombinant pox virus for immunization against muc1 tumor-associated antigen |
-
1998
- 1998-10-30 IT IT1998MI002330A patent/IT1303683B1/it active
-
1999
- 1999-10-18 JP JP2000579265A patent/JP2002528519A/ja active Pending
- 1999-10-18 PL PL99348156A patent/PL348156A1/xx unknown
- 1999-10-18 TR TR2001/01141T patent/TR200101141T2/xx unknown
- 1999-10-18 SK SK571-2001A patent/SK5712001A3/sk unknown
- 1999-10-18 EP EP99971329A patent/EP1124956A2/en not_active Withdrawn
- 1999-10-18 WO PCT/EP1999/007874 patent/WO2000025827A2/en not_active Application Discontinuation
- 1999-10-18 EA EA200100395A patent/EA200100395A1/ru unknown
- 1999-10-18 CA CA002348745A patent/CA2348745A1/en not_active Abandoned
- 1999-10-18 BR BR9914892-7A patent/BR9914892A/pt not_active IP Right Cessation
- 1999-10-18 CZ CZ20011521A patent/CZ20011521A3/cs unknown
- 1999-10-18 AU AU11522/00A patent/AU1152200A/en not_active Abandoned
- 1999-10-18 HU HU0103784A patent/HUP0103784A2/hu unknown
- 1999-10-18 MX MXPA01004186A patent/MXPA01004186A/es unknown
- 1999-10-18 CN CN99812745A patent/CN1324406A/zh active Pending
- 1999-10-21 AR ARP990105316A patent/AR020927A1/es unknown
- 1999-10-22 PE PE1999001068A patent/PE20001287A1/es not_active Application Discontinuation
- 1999-10-29 CO CO99068636A patent/CO5231134A1/es not_active Application Discontinuation
-
2001
- 2001-04-20 BG BG105458A patent/BG105458A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI982330A1 (it) | 2000-04-30 |
| EA200100395A1 (ru) | 2001-10-22 |
| WO2000025827A3 (en) | 2000-08-10 |
| SK5712001A3 (en) | 2002-04-04 |
| JP2002528519A (ja) | 2002-09-03 |
| AR020927A1 (es) | 2002-06-05 |
| MXPA01004186A (es) | 2002-06-04 |
| ITMI982330A0 (it) | 1998-10-30 |
| CN1324406A (zh) | 2001-11-28 |
| BG105458A (en) | 2002-06-28 |
| TR200101141T2 (tr) | 2001-09-21 |
| CZ20011521A3 (cs) | 2001-10-17 |
| WO2000025827A2 (en) | 2000-05-11 |
| HUP0103784A2 (hu) | 2002-02-28 |
| PE20001287A1 (es) | 2000-12-07 |
| EP1124956A2 (en) | 2001-08-22 |
| IT1303683B1 (it) | 2001-02-23 |
| BR9914892A (pt) | 2001-07-17 |
| AU1152200A (en) | 2000-05-22 |
| CA2348745A1 (en) | 2000-05-11 |
| PL348156A1 (en) | 2002-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5231134A1 (es) | Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica con efecto antitumoral | |
| ATE335510T1 (de) | Methoden und produkte zur induzierung mukosaler immunität | |
| AR049177A1 (es) | Polipeptidos y conjugados de interferon-alfa | |
| BR9811462A (pt) | Moléculas de tnfalfa modificadas, dna que codifica tais moléculas de tnfalfa modificadas e vacinas que compreendem tais tnfalfa modificadas e dna. | |
| AR058249A2 (es) | Una molecula aislada de polinucleotido que comprende una secuencia de adn que codifica una molecula infecciosa de arn que codifica un virus prrs norteamericano, celula transfectada y vacuna | |
| CY1105555T1 (el) | Ανθρωπινα πολυπεπτιδια pellino | |
| IL191982A0 (en) | Breast cancer resistance protein (bcrp) and the dna which encodes it | |
| DK153685A (da) | Immunogent middel, der kan indgives oralt, og fremgangsmaade til dets fremstilling | |
| ES2183486T3 (es) | Formulaciones de fsh y de variantes de fsh que comprenden alcohol bencilico como agente preservativo. | |
| NO992102D0 (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
| NO944245L (no) | Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| AR020588A1 (es) | Un polinucleotido aislado destinado a alterar la actividad de liberacion del receptor del factor de necrosis tumoral, un polipeptido codificado por dichopolinucleotido, metodo para producirlo, un anticuerpo especifico para dicho polipeptido, metodos de ensayo para determinar la actividad alterada de | |
| ES2146214T3 (es) | Vacunas para actinobacillus pleuropneumoniae. | |
| AR039846A1 (es) | Molecula de acido nucleico que codifica un antigeno de muc-1, siendo dicha molecula capaz de producir una respuesta inmune in vivo | |
| BR9708005A (pt) | C3 convertase resistente à regulação para baixo | |
| BR9913132A (pt) | Nucleotìdeos da antitrombina e proteìnas do moscão | |
| MD2053C2 (ro) | Remediu cu acţiune interferonogenă | |
| DK0980379T3 (da) | Chimære oligonucleotider og deres anvendelse | |
| DK1664097T3 (da) | Piroplasmidvaccine | |
| HUP0200832A2 (hu) | Babesia canis oltóanyag | |
| Leslie | Regaining one's marbles | |
| AR027791A1 (es) | Proteinas de fusion con hemolisina, produccion y uso de las mismas | |
| AR028828A1 (es) | Acidos nucleicos y polipeptidos de la fitil/preniltransferasa, y usos de los mismos | |
| RU95101019A (ru) | Способ получения фактора некроза опухоли, фактор некроза опухоли, днк, клетка, композиция |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |